Sinopharm Yizhi: Net profit in 2025 is expected to increase 76.8% year-on-year; it plans to issue 10 shares for 1 share (bonus) and pay a dividend of 6.16 yuan.

2026-04-04 03:08:48

People’s Finance News, April 1—Guoyi Consistent Pharmaceutical (000028) disclosed its annual report on April 1. In 2025, the company achieved operating revenue of 73.42B yuan, down 1.29% year over year; attributable net profit to shareholders was 1.14B yuan, up 76.8% year over year; and basic earnings per share were 2.04 yuan. The company plans to distribute a cash dividend of 6.16 yuan for every 10 shares (tax included), and to issue 1 bonus share for every 10 shares (tax included). During the reporting period, attributable net profit grew year over year; the main reason was that the year-over-year decrease in asset impairment provisions recorded for goodwill and intangible assets totaled 686M yuan, together with the decline in rigid cost items such as labor and rent resulting from store adjustments.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.